Tempus AI Change in Accounts Payable 2023-2025 | TEM

Tempus AI annual/quarterly change in accounts payable history and growth rate from 2023 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
  • Tempus AI change in accounts payable for the quarter ending June 30, 2025 was $0.007B, a 121.05% decline year-over-year.
  • Tempus AI change in accounts payable for the twelve months ending June 30, 2025 was $-0.018B, a 77.75% decline year-over-year.
  • Tempus AI annual change in accounts payable for 2024 was $-0.024B, a 2.09% increase from 2023.
  • Tempus AI annual change in accounts payable for 2023 was $-0.023B, a 195.17% increase from 2022.
  • Tempus AI annual change in accounts payable for 2022 was $-0.008B, a 0% decline from .
Tempus AI Annual Change in Accounts Payable
(Millions of US $)
2024 $-24
2023 $-23
2022 $-8
Sector Industry Market Cap Revenue
Medical Medical Information Systems $13.327B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Doximity (DOCS) United States $12.012B 53.44
Hims & Hers Health (HIMS) United States $9.936B 81.41
IRhythm Technologies (IRTC) United States $5.355B 0.00
Hinge Health (HNGE) United States $4.369B 0.00
Inspire Medical Systems (INSP) United States $2.710B 39.83
Privia Health (PRVA) United States $2.618B 193.91
Heartflow (HTFL) $2.348B 0.00
Phreesia (PHR) United States $1.711B 0.00
Enovis (ENOV) United States $1.686B 8.91
10x Genomics (TXG) United States $1.631B 0.00
Omnicell (OMCL) United States $1.465B 28.22
Schrodinger (SDGR) United States $1.441B 0.00
Azenta (AZTA) United States $1.368B 59.68
Clover Health Investments (CLOV) United States $1.338B 0.00
Claritev (CTEV) United States $1.131B 0.00
Evolent Health (EVH) United States $1.030B 0.00
Fulgent Genetics (FLGT) United States $0.655B 0.00
Zepp Health (ZEPP) Netherlands $0.580B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.458B 0.00
Talkspace (TALK) United States $0.456B 136.00
Butterfly Network (BFLY) United States $0.350B 0.00
Carlsmed (CARL) United States $0.342B 0.00
TruBridge (TBRG) United States $0.296B 51.87
Outset Medical (OM) United States $0.243B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.232B 0.00
Nyxoah SA (NYXH) Belgium $0.216B 0.00
Health Catalyst (HCAT) United States $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.186B 0.00
MDxHealth SA (MDXH) Belgium $0.145B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.121B 0.00
CareCloud (CCLD) United States $0.115B 5.23
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.071B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.062B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.037B 0.00
Precipio (PRPO) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
PROFUSA (PFSA) United States $0.015B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00